CANNULA PR-110Q-1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a literature report with the FDA on 2018-12-17 for CANNULA PR-110Q-1 manufactured by Olympus Medical Systems Corp..

Event Text Entries

[130618390] The subject device was not returned to olympus medical systems corp. (omsc) for evaluation. The malfunction of the subject device was not reported. The subject device is done the 100% inspection. The author has not provided additional information about individual cases. Therefore, the exact cause of the reported event could not be conclusively determined. Omsc assumes that the cause of this event is not related to the malfunction of the device. It was known that the endo-therapy devices using for the biliary or pancreatic tree could lead to a pancreatitis. The instruction manual of the device has already noted as follows; limited studies indicate that: acute pancreatitides are caused most frequently as cases of post- diagnostic ercp, and that 50% of the causes of deaths are made up of pancreatitis? Becoming severe; this is followed by perforation, and most of the site of perforation are descending limb. Limited studies indicate that acute pancreatitides following ercp are mostly mild cases; however, once in a while, severe cases exist, in which failure of multiple organs and disseminated intravascular coagulation are developed successively leading to death.
Patient Sequence No: 1, Text Type: N, H10


[130618391] In the paper "efficacy and safety of pancreatic juice cytology by using synthetic secretin in the diagnosis of pancreatic ductal adenocarcinoma", published in the journal "digestive endoscopy 2018; 30: 771-776", the following were reported; 138 cases of pancreatic juice cytology (pjc) were done to detect the pancreatic ductal adenocarcinoma (pdac). The subject product or (b)(4) (boston scientific) was used for pjc. 12 patients suffered mild pancreatitis as a complication. All 12 patients were immediately cured with conservative medical treatment. It was unknown whether the subject product was used in the mild pancreatitis-occurred cases. The malfunction of the subject product was not reported. This is the report regarding the occurring of the pancreatitis.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010047-2018-02445
MDR Report Key8171833
Report SourceLITERATURE
Date Received2018-12-17
Date of Report2018-12-18
Date Mfgr Received2018-11-29
Date Added to Maude2018-12-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR KAZUTAKA MATSUMOTO
Manufacturer Street2951 ISHIKAWA-CHO
Manufacturer CityHACHIOJI-SHI, TOKYO-TO 192-8507
Manufacturer CountryJA
Manufacturer Postal192-8507
Manufacturer Phone426425177
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCANNULA
Generic NameCANNULA
Product CodeODD
Date Received2018-12-17
Model NumberPR-110Q-1
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerOLYMPUS MEDICAL SYSTEMS CORP.
Manufacturer Address2951 ISHIKAWA-CHO HACHIOJI-SHI, TOKYO-TO 192-8507 JA 192-8507


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-12-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.